Julia A Beaver1, Paul G Kluetz1, Richard Pazdur1. 1. From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research (J.A.B.), and the Oncology Center of Excellence (P.G.K., R.P.), U.S. Food and Drug Administration, Silver Spring, MD; and the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, Washington, DC (J.A.B.).
Authors: Melania Rivano; Luca Cancanelli; Lorenzo Di Spazio; Daniele Mengato; Marco Chiumente; Andrea Messori Journal: World J Urol Date: 2022-09-09 Impact factor: 3.661
Authors: Juan M Arriaga; Sukanya Panja; Mohammed Alshalalfa; Junfei Zhao; Min Zou; Arianna Giacobbe; Chioma J Madubata; Jaime Yeji Kim; Antonio Rodriguez; Ilsa Coleman; Renu K Virk; Hanina Hibshoosh; Onur Ertunc; Büşra Ozbek; Julia Fountain; R Jeffrey Karnes; Jun Luo; Emmanuel S Antonarakis; Peter S Nelson; Felix Y Feng; Mark A Rubin; Angelo M De Marzo; Raul Rabadan; Peter A Sims; Antonina Mitrofanova; Cory Abate-Shen Journal: Nat Cancer Date: 2020-10-19